Equities research analysts expect that AmerisourceBergen Corp. (NYSE:ABC) will announce earnings per share of $1.81 for the current quarter, according to Zacks Investment Research. Seven analysts have issued estimates for AmerisourceBergen’s earnings. The highest EPS estimate is $2.00 and the lowest is $1.70. AmerisourceBergen posted earnings per share of $1.77 in the same quarter last year, which indicates a positive year over year growth rate of 2.3%. The business is scheduled to issue its next earnings results on Thursday, May 3rd.
On average, analysts expect that AmerisourceBergen will report full-year earnings of $6.51 per share for the current fiscal year, with EPS estimates ranging from $6.00 to $6.64. For the next financial year, analysts forecast that the company will report earnings of $7.33 per share, with EPS estimates ranging from $6.65 to $7.85. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research firms that follow AmerisourceBergen.
AmerisourceBergen (NYSE:ABC) last issued its earnings results on Tuesday, February 6th. The company reported $1.55 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.35 by $0.20. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The company had revenue of $40.47 billion during the quarter, compared to the consensus estimate of $40.42 billion. During the same period in the previous year, the company posted $1.36 EPS. The firm’s revenue for the quarter was up 6.0% compared to the same quarter last year.
Several research firms recently issued reports on ABC. Mizuho set a $100.00 price target on AmerisourceBergen and gave the company a “hold” rating in a research note on Wednesday, January 24th. Needham & Company LLC boosted their price target on AmerisourceBergen from $88.00 to $108.00 and gave the company a “buy” rating in a research note on Tuesday, January 23rd. Zacks Investment Research upgraded AmerisourceBergen from a “hold” rating to a “buy” rating and set a $111.00 price target for the company in a research note on Thursday, January 18th. Evercore ISI began coverage on AmerisourceBergen in a research note on Thursday, January 4th. They issued an “outperform” rating and a $105.00 price target for the company. Finally, TheStreet upgraded AmerisourceBergen from a “c” rating to a “b” rating in a research note on Tuesday, February 6th. One research analyst has rated the stock with a sell rating, six have given a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $101.17.
Shares of AmerisourceBergen (ABC) traded up $0.08 during midday trading on Tuesday, hitting $99.48. The stock had a trading volume of 1,021,188 shares, compared to its average volume of 2,210,091. The company has a market cap of $21,850.00, a P/E ratio of 56.90, a P/E/G ratio of 1.59 and a beta of 1.02. AmerisourceBergen has a one year low of $71.90 and a one year high of $106.27. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.95 and a quick ratio of 0.50.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 5th. Shareholders of record on Tuesday, February 20th will be issued a $0.38 dividend. The ex-dividend date of this dividend is Friday, February 16th. This represents a $1.52 annualized dividend and a yield of 1.53%. AmerisourceBergen’s dividend payout ratio is presently 86.86%.
In other news, CFO Tim G. Guttman sold 11,600 shares of the business’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $85.73, for a total transaction of $994,468.00. Following the completion of the transaction, the chief financial officer now owns 56,436 shares of the company’s stock, valued at approximately $4,838,258.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman Steven H. Collis sold 21,350 shares of the business’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $82.53, for a total value of $1,762,015.50. Following the transaction, the chairman now directly owns 287,925 shares of the company’s stock, valued at approximately $23,762,450.25. The disclosure for this sale can be found here. Insiders sold a total of 200,896 shares of company stock valued at $18,169,965 over the last ninety days. Insiders own 27.30% of the company’s stock.
Institutional investors have recently bought and sold shares of the company. Hikari Tsushin Inc. acquired a new position in shares of AmerisourceBergen during the 4th quarter worth $106,000. Delpha Capital Management LLC bought a new stake in AmerisourceBergen during the 4th quarter worth $137,000. Vantage Investment Advisors LLC bought a new stake in AmerisourceBergen during the 4th quarter worth $156,000. Intl Fcstone Inc. bought a new stake in AmerisourceBergen during the 2nd quarter worth $201,000. Finally, TRUE Private Wealth Advisors bought a new stake in AmerisourceBergen during the 4th quarter worth $203,000. 65.98% of the stock is owned by institutional investors.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.